ADAP Down 46% This Month, CLVS Abuzz, ADRO Awaits Data In Nov.

ADAP Down 46% This Month, CLVS Abuzz, ADRO Awaits Data In Nov.
The following are some of the pharma/biotech stocks that posted the biggest percentage decline today. 1. Adaptimmune Therapeutics plc (ADAP) Adaptimmune is a clinical-stage biopharmaceutical company developing novel cancer immunotherapy products. Lost 29.83% to close Monday’s (Oct.22) trading at 7.55. Pipeline: The Company is developing engineered T cell therapies like MAGE-A10, MAGE-A4, AFP and NY-ESO. — The MAGE-A4 SPEAR T-cell... Read More

Asian Markets In Negative Territory

Asian Markets In Negative Territory
Asian stock markets are in negative territory on Tuesday following the lackluster cues overnight from Wall Street amid rising geopolitical tensions around the world and on worries about Italy’s budgetary woes as well as Brexit. Investors are also cautious as they focus on several major upcoming corporate earnings results due this week. The Australian market is extending losses from the... Read More

Supreme Court blocks deposition from Commerce Sect. Ross in census-citizenship suit

Supreme Court blocks deposition from Commerce Sect. Ross in census-citizenship suit
The U.S. Supreme Court Monday said that states and interest groups suing the Department of Commerce over its intent to include a citizenship question on the 2020 Census cannot compel a deposition from Commerce Sect. Wilbur Ross. Justice Neil Gorsuch, in an order posted on the court’s website, said a federal district court overstepped in ordering the deposition and said... Read More

PETX On The Move, TTOO To Report Q3 Results On Nov.1, CLGN Inks Deal With UTHR

PETX On The Move, TTOO To Report Q3 Results On Nov.1, CLGN Inks Deal With UTHR
The following are some of today’s top gainers in the pharma/biotech sector. 1. Soleno Therapeutics Inc. (SLNO) The Company is developing therapeutics for the treatment of rare diseases. Gained 19.58% to close Monday’s (Oct.22) trading at $2.26. News: No news Pipeline: The lead drug candidate is Diazoxide Choline Controlled-Release (DCCR), under phase III testing for the treatment of Prader-Willi Syndrome.... Read More

Tesla to report earnings Wednesday

Tesla to report earnings Wednesday
Tesla Inc. TSLA, +0.37% said late Monday evening that it expects to report third-quarter earnings after the closing bell Wednesday. Tesla stock was down 0.3% in after hours trading. The company will host a conference call at 5:30 p.m. Eastern time to discuss the quarter and outlook. Tesla stock is down 16% this year, as the S&P 500 index SPX,... Read More

Small medical pot companies plan to merge in $48 million stock deal

Small medical pot companies plan to merge in $48 million stock deal
Small Canada-based marijuana producer FSD Pharma Inc. FSDDF, -19.60% said late Monday it intends to acquire Therapix Biosciences Ltd. TRPX, +2.79% for $48 million in stock. FSD said that it has a license to cultivate medical marijuana in Canada and has been harvesting cannabis since last month, though the company did not disclose the quantity. MarketWatch was unable to immediately... Read More

Cadence stock jumps 8% on earnings beat

Cadence stock jumps 8% on earnings beat
Shares of Cadence Design Systems Inc. CDNS, +1.25% rallied more than 8% in the extended session Monday after the software and engineering company reported third-quarter earnings above Wall Street expectations. Cadence said it earned $95 million, or 34 cents a share, in the third quarter, compared with $81 million, or 29 cents a share, in the same period in 2017.... Read More